Navigation Links
RX600 Fracture Table

ProductsRX600 Fracture Table
Company Eschmann Equipment
Item RX600 Fracture Table
Features 
  • Fully powered operating table for orthopaedic and trauma surgery with integral double articulated beams complete with antistatic mattress
  • Traction beams can be stowed beneath top when not in use, allowing table to be used for a full range of surgical procedures
  • Includes a pair of lightweight leg supports for pre-traction positioning
  • 24 volt batteries with charger unit and power cable stored in base
  • Brakes, wheels and castors applied by handset
  • Description The RX600 is a versatile, fully powered orthopaedic and trauma table. Its impressive range of built-in traction facilities, a powered centre break and unimpeded image intensifier access make it extremely versatile too.
    Info Eschmann Equipment
    Customer Service: +44 1903 753322
    Web site: http://www.eschmann.co.uk/

    Related medicine products :

    1. Boies Nasal Fracture Elevator
    2. Exogen 2000+, or Sonic Accelerated Fracture Healing System (SAFHS)
    3. Amsco OrthoVision Orthopedic and Fracture Table
    4. ProFix™ Fracture
    5. Becton™ Colles Fracture Plate
    6. Humerus Fracture Brace
    7. Humeral Fracture Orthosis (standard cuff model)
    8. Humeral Fracture Orthosis (over-the-shoulder)
    9. FREEDOM® Boxer Fracture Prefab Orthosis
    10. Ulna Fracture Orthosis
    11. Tibial Fracture Orthosis (Sarmiento style)
    Other Medicine News:Health News:ADA Urges President Bush Not to Veto Critical Appropriations Bill 2Health News:AUA releases new guidelines on non-muscle invasive bladder cancer 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 3Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 4Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 5Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 6Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 7Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 8Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 9Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 10Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 11Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 12Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 13Health News:New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees 2Health News:Physics provides new insights on cataract formation 2
    Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 1Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 2All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 1All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 1Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 3